Page last updated: 2024-12-07

idph-791

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID127161
CHEMBL ID460904
SCHEMBL ID8989315
MeSH IDM0191194

Synonyms (19)

Synonym
idph-791
brn 4807179
1h-(1,2,4)triazolo(3,4-c)(1,4)benzothiazin-1-one, 2,4-dihydro-
1-oxo-2,4-dihydro(1,2,4)triazolo(3,4-c)(1,4)benzothiazine
2,4-dihydro-1h-(1,2,4)triazolo(3,4-c)(1,4)benzothiazin-1-one
HMS1664H11
2,4-dihydro-1h-[1,2,4]triazolo[3,4-c][1,4]benzothiazin-1-one
hts-12932
CHEMBL460904
98827-47-5
2,4-dihydro-[1,2,4]triazolo[3,4-c][1,4]benzothiazin-1-one
1-oxo-2,4-dihydro-s-triazolo(3,4-c)(1,4)benzothiazine
idph 791
SCHEMBL8989315
DTXSID80243832
CCG-238844
sr-01000003577
SR-01000003577-1
PD159981

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"IDPH-791, a novel centrally acting muscle relaxant, in doses up to 500 mg/kg (po) for 14 days did not result in any appreciable adverse effect on body weight gain, food or water consumption including biochemical and haematologica parameters in rats."( Pre-clinical toxicity of IDPH-791: a new centrally acting muscle relaxant in rats.
Junnarkar, AY; Krishnamurthy, A; Marathe, MR; Rajasekaran, M; Singh, PP; Thapar, GS; Varma, RK, 1991
)
2.03
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID345874Inhibition of human recombinant EGFR at 100 uM2009Journal of medicinal chemistry, Feb-26, Volume: 52, Issue:4
Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies.
AID638469Inhibition of His-tagged recombinant human IDO1 expressed in Escherichia coli using tryptophan as substrate at 200 uM by spectrophotometric analysis2012Bioorganic & medicinal chemistry, Feb-01, Volume: 20, Issue:3
Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]